Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming investor conferences:
- H.C. Wainwright Annual Global Life Sciences Conference
Event Date: May 23-25, 2022
- Citi’s European Healthcare Conference
Event Date: June 16, 2022
| Press Release in English | 140.77 KB |
| Communiqué en français | 144.04 KB |